Skip to main content
Civitas.Global
PoliticsSouth Africa

McKinsey & Co. Settles South Africa Bribery Allegations with $122 Million Payment

The global consulting firm faces legal repercussions for alleged bribery connected to state-owned entities in South Africa.

By Michael Forsythe and Walt BogdanichSource: nytimes.com1 min read
McKinsey & Co. Settles South Africa Bribery Allegations with $122 Million Payment
Image via nytimes.com

In brief

McKinsey & Co. has agreed to a $122 million settlement regarding bribery allegations in South Africa, part of a broader pattern of legal challenges faced by the firm. A former senior partner has also pleaded guilty to conspiracy charges related to the case.

In a significant legal development, McKinsey & Co. has reached a settlement involving a payment of over $122 million to resolve a felony bribery investigation linked to its operations in South Africa. Announced by federal prosecutors in New York, this latest agreement highlights ongoing legal troubles for the international consulting giant. This payment is a part of a deferred prosecution agreement that could see the bribery charges dismissed after three years, contingent on McKinsey adhering to the stipulations set forth in the deal. Alongside the settlement, Vikas Sagar, a former senior partner who headed the firm's Johannesburg office, entered a guilty plea for conspiring to breach anti-corruption laws. The investigation focused on McKinsey's association with two state-owned enterprises in South Africa, revealing that the firm allegedly engaged in a multi-year scheme where confidential information led to lucrative contracts while routing bribes to government officials.According to U.S. attorney Damian Williams, McKinsey Africa's actions were part of a broader scheme to corruptly secure consulting engagements, reaping approximately $85 million in dishonest profits. Previous inquiries into McKinsey's contracts in South Africa have cast the firm’s actions there as perhaps its most significant misstep in a century of operations. This incident adds to McKinsey’s swath of legal issues; the firm has also settled around $1 billion in other matters, particularly concerning its involvement with opioid manufacturers. The ramifications of McKinsey's actions continue to unfold in the wake of its controversial role in promoting the sale of OxyContin amid the U.S. opioid crisis, underlining a troubling narrative about corporate governance and accountability.

Topics

More on this story